Back to Peptides
Snap-8
Anti-Aging & Skin HealthSnap-8 is a topical cosmetic peptide used to reduce the appearance of fine lines and wrinkles by inhibiting facial muscle contractions. It mimics the effect of Botox but is applied non-invasively, making it ideal for long-term wrinkle control and skin smoothing.
Reconstitute
3 mL BAC + 10mg vial
33 mcg/unit
Daily Range
200–500 mcg Topical
Twice daily
Standard Dose
300 mcg
Cycle
4–8 weeks
then reassess
Snap-8wrinkle peptidebotox alternativeanti-agingneuromodulator
Dosing & Reconstitution Guide
Cosmetic products typically contain 3–10% concentrations. This peptide is not approved for injection or systemic use.
Standard / Gradual Approach
10mg VialstandardPhaseDoseVolume
Weeks 1–4330 mcg (0.33 mg)10 units (0.10 mL)
Weeks 5–8500 mcg (0.50 mg)15 units (0.15 mL)
Weeks 9–121,000 mcg (1.0 mg)30 units (0.30 mL)
Weeks 13–16 (Optional)1,000 mcg (1.0 mg)30 units (0.30 mL)
Protocol Summary
Topical: Twice daily · Dose range 200–500 mcg with gradual titration
Cycle Length: 4–8 weeks typical; reassess before extending
Frequency & Cycling
Topical
Apply twice daily to wrinkle-prone areas. Continuous use recommended for best cosmetic effect; maintenance cycles may continue indefinitely.
🧪 Quick Start
Vial Size
10 mg
BAC Water
3 mL
Concentration
3.33 mcg/unit
Starting Dose
330 mcg (0.33 mg) (10 units (0.10 mL))
Maintenance Dose
1,000 mcg (1.0 mg) (30 units (0.30 mL))
Potential Benefits & Use Cases
SNAP-8 is a cosmetic ingredient, not a therapeutic peptide. Not intended for medical or injectable applications.
Reduces wrinkle depth by ~35% on average, up to 60% in certain areas after 28–30 days of consistent application (human trial)
Microneedle patch trial (24 subjects): significant eye wrinkle reduction and improved skin elasticity over 4 weeks (human trial)
Multi-peptide serum study (14 weeks): statistically significant smoothing of expression lines (human trial)
Stimulates fibroblast collagen production for enhanced skin firmness (preclinical)
No systemic toxicity observed at typical doses (human trial)
Clinical data Strong preclinical Limited data
Mechanism of Action
→Inhibits SNARE complex assembly, reducing neurotransmitter release
→Limits muscle contraction in the facial region, reducing expression lines
→Blocks calcium-dependent vesicle fusion at the neuromuscular junction
→Mimics botulinum-like muscle relaxation effects without injection
Lifestyle & Optimization
timing
Topical application as part of daily skincare routine.
diet
Adequate hydration.
exercise
General health maintenance.
sleep
Quality sleep for skin repair. Broad-spectrum SPF. Consider combining with retinoids, vitamin C, and hyaluronic acid.
Peptide Research & Preclinical Studies
Evidence-Based Research Findings
Study TitleType
Side Effects & Safety
Common Side Effects
• Mild irritation at higher concentrations (>3–10%) (user-reported)
• Mild reactions when combined with retinoids and vitamin C (user-reported)
🧮 Dose Calculator
Concentration
33.3
mcg/unit
Draw Volume
15
units (0.150 mL)
For a 500 mcg dose, draw 15 units on a U-100 insulin syringe
🧬
Bioavailability & Absorption
SubQ Injection
Not used via this route
Oral Administration
Not suitable due to peptide degradation
Half-Life
Estimated under 24 hours for topical stability
Degradation
Primarily broken down by proteases at the skin surface
Tissue Specificity
Acts locally at dermal neuromuscular junctions in the facial area
⚗️
Peptide Details
Molecular Weight
1075.16
Formula
C41H70N16O16S
Sequence
Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH2
⚖️
Legal Status & Regulatory
RegionStatus
FDANot Approved
EUNot Approved
AustraliaNot Approved
CanadaNot Approved
Storage Instructions
Lyophilized (Powder)
freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles
Reconstituted (Mixed)
Refrigerate at 2–8 °C (35.6–46.4 °F); use within 30 days for maximum potency